Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population

Clinical Infectious Diseases

Volumn 60, Issue 11, 2015, Pages 1631-1638

  Currier, Rebecca L ^a,b,c   Payne, Daniel C ^d   Staat, Mary A ^a   Selvarangan, Rangaraj ^e,f   Shirley, S Hannah ^d,g   Halasa, Natasha ^h   Boom, Julie A ⁱ   Englund, Janet A ^j   Szilagyi, Peter G ^k   Harrison, Christopher J ^e,f   Klein, Eileen J ^j   Weinberg, Geoffrey A ^k   Wikswo, Mary E ^d   Parashar, Umesh ^d   Vinjé, Jan ^d   Morrow, Ardythe L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e CHILDREN S MERCY HOSPITAL   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^g Atlanta Research and Education Foundation Inc   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

diarrhea; FUT2; gastroenteritis; histo blood group antigens; norovirus

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; UNCLASSIFIED DRUG; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONSENSE MUTATION; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; UNITED STATES; VIRUS DETECTION; CALICIVIRUS INFECTION; CASE CONTROL STUDY; CLASSIFICATION; FECES; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

CALICIVIRIDAE INFECTIONS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FECES; FEMALE; FUCOSYLTRANSFERASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NOROVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84930393346     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ165     Document Type: Article

References (35)

1. Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14:725-30.
2. Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. B Infect Dis 2014; 58:1746-52.
3. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. Systematic literature review of role of noroviruses in sporadic gastroenteritis. B Infect Dis 2008; 14:1224-31.
4. Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerg Infect Dis 2013; 19:1198-205.
5. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:1776-85.
6. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol 2014; 52:147-55.
7. Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G, Blanchard D, Le Pendu J. Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol 2000; 74:11950-4.
8. Han L, Kitov PI, Kitova EN, et al. Affinities of recombinant norovirus P dimers for human blood group antigens. Glycobiology 2013; 23:276-85.
9. Tian P, Yang D, Jiang X, et al. Specificity and kinetics of norovirus binding to magnetic bead-conjugated histo-blood group antigens. J Appl Microbiol 2010; 109:1753-62.
10. Bucardo F, Kindberg E, Paniagua M, et al. Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol 2009; 81:728-35.
11. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548-53.
12. Frenck R, Bernstein DI, Xia M, et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis 2012; 206:1386-93.
13. Carlsson B, Kindberg E, Buesa J, et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One 2009; 4:e5593.
14. Tan M, Jin M, Xie H, Duan Z, Jiang X, Fang Z. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 2008; 80:1296-301.
15. Van Trang N, Vu HT, Le NT, Huang P, Jiang X, Anh DD. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol 2014; 52:1366-74.
16. Nordgren J, Kindberg E, Lindgren PE, Matussek A, Svensson L. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg Infect Dis 2010; 16:81-7.
17. Ferrer-Admetlla A, Sikora M, Laayouni H, et al. A natural history of FUT2 polymorphism in humans. Mol Biol Evol 2009; 26:1993-2003.
18. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977; 297:86-9.
19. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121-30.
20. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013; 57:13-20.
21. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinje J. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. B Infect Dis 2011; 17:1389-95.
22. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011; 13:101.
23. Rummel S, Shriver CD, Ellsworth RE. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotypephenotype correlation study. BMC Med Genet 2012; 13:41.
24. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5:e1000529.
25. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155:945-59.
26. Nordgren J, Nitiema LW, Ouermi D, Simpore J, Svensson L. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. B One 2013; 8:e69557.
27. Liu P, Wang X, Lee JC, et al. Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr Infect Dis J 2014; 33:e305-9.
28. Atmar RL, Opekun AR, Gilger MA, et al. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis 2014; 209:1016-22.
29. Nordgren J, Sharma S, Bucardo F, et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype- dependent manner. Clin Infect Dis 2014; 59:1567-73.
30. Imbert-Marcille BM, Barbe L, Dupe M, et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. B Infect Dis 2014; 209:1227-30.
31. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005; 135:1304-7.
32. Jiang X, Huang P, Zhong W, Morrow AL, Ruiz-Palacios GM, Pickering LK. Human milk contains elements that block binding of noroviruses to histo-blood group antigens in saliva. Adv ExpMed Biol 2004; 554:447-50.
33. Newburg DS, Ruiz-Palacios GM, Altaye M, et al. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 2004; 14:253-63.
34. Lopman BA, Trivedi T, Vicuna Y, et al. Norovirus infection and disease in an Ecuadorian birth cohort: association of certain norovirus genotypes with host FUT2 secretor status. J Infect Dis 2014; doi:10.1093/infdis/jiu672.
35. Morrow AL, Meinzen-Derr J, Huang P, et al. Fucosyltransferase 2 nonsecretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 2011; 158:745-51.